This inventor holds 2 USPTO granted patents. Top assignee: Canon Kabushiki Kaisha. Active years: 2014-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Chandgaon, JP (2014)
- Kyoto, JP (2015)
Company Filing History:
Years Active: 2014-2015
Title: Zainul Abedin Siddique: Innovator in MRI Contrast Agents
Introduction
Zainul Abedin Siddique is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of medical imaging, particularly in the development of MRI contrast agents. With a total of 2 patents, his work focuses on enhancing the effectiveness of these agents for better diagnostic capabilities.
Latest Patents
Siddique's latest patents include innovative compounds that utilize metal complexes to improve T1-reducing effects. One of his patents describes a core of a cyclic structure represented by (—N—(CH)—) bonded to a dendrimer-type side chain. This specific branched structure at all nitrogen atoms in the core produces a compound designed to create a metal complex with excellent T1-reducing properties. This complex is particularly useful as an effective component of MRI contrast agents. Another patent further explores AZA compounds and their production methods, emphasizing their application as MRI contrast agents.
Career Highlights
Zainul Abedin Siddique is currently employed at Canon Kabushiki Kaisha, where he continues to innovate in the field of medical imaging. His work has garnered attention for its potential to significantly enhance MRI technology.
Collaborations
Siddique collaborates with esteemed colleagues such as Teruyuki Kondo and Hiroshi Tsujita. Their combined expertise contributes to the advancement of research and development in MRI contrast agents.
Conclusion
Zainul Abedin Siddique's contributions to the field of MRI contrast agents highlight his innovative spirit and dedication to improving medical imaging technology. His patents reflect a commitment to enhancing diagnostic capabilities, making a significant impact in the healthcare industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
